HK Stock Market Move | KINGDEE INT'L (00268) rises over 7%; Q3 net new ARR approximately RMB 191 million; company's AI order conversion begins to accelerate.
KINGDEE INT'L (00268) rose over 7%, up 7.17% as of press time to HK$8.97, with a turnover of HK$324 million.
KINGDEE INT'L (00268) rose over 7%, up 7.17% as of press time to HK$8.97, with turnover of HK$324 million.
On the news front, KINGDEE INT'L recently disclosed its Q3 2026 report. As of the end of September 2026, the company's subscription service ARR was approximately RMB 4.604 billion, up about 19.3% year-on-year, with net new ARR of approximately RMB 191 million in Q3 alone, up about 46.9% year-on-year. In addition, in the first three quarters of this year, the cumulative contract value signed for the company's AI-native products reached RMB 1.002 billion, with new contract values of RMB 230 million, 375 million, and 397 million in Q1, Q2, and Q3 respectively, maintaining a quarter-on-quarter growth trend, reflecting that the company's AI order conversion has begun to accelerate.
It is worth noting that on October 23, the 2026 Kingdee Global Visionaries Conference will be held in Beijing. With the theme of "Making Every Enterprise an AI-Native Organization," this year's conference will unfold around three main threads: AI management philosophy, AI management technology, and AI management practice, focusing on improving work efficiency, decision-making capability, and business wisdom.
Related Articles

Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) Subsidiary's Product Eribulin Mesylate Injection Receives U.S. FDA Approval

HK Stock Market Move | Most mainland property stocks under pressure; September new home sales decline widens; overall real estate industry remains in a divergent landscape

HK Stock Market Move | AGTECH HOLDINGS (08279) rose more than 10% in late trading; Hong Kong Gold Settlement plans to connect to currency settlement before the end of the year.
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) Subsidiary's Product Eribulin Mesylate Injection Receives U.S. FDA Approval

HK Stock Market Move | Most mainland property stocks under pressure; September new home sales decline widens; overall real estate industry remains in a divergent landscape

HK Stock Market Move | AGTECH HOLDINGS (08279) rose more than 10% in late trading; Hong Kong Gold Settlement plans to connect to currency settlement before the end of the year.






